NCT04595422 Educating Smokers About Lung Cancer Screening Using Tobacco Quitlines
| NCT ID | NCT04595422 |
| Status | Recruiting |
| Phase | — |
| Sponsor | M.D. Anderson Cancer Center |
| Condition | Lung Carcinoma |
| Study Type | INTERVENTIONAL |
| Enrollment | 800 participants |
| Start Date | 2020-07-02 |
| Primary Completion | 2026-10-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 800 participants in total. It began in 2020-07-02 with a primary completion date of 2026-10-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This implementation study will examine the best ways to refer heavy smokers to information about lung cancer screening.
Eligibility Criteria
Inclusion Criteria: * QUITLINE CALL CENTER STAFF * Staff member of a quitline * Aged 18 years and above * CALLERS (SMOKERS WHO CONTACT THE QUITLINE ABOUT SMOKING CESSATION SERVICES) INCLUSION CRITERIA * Callers 55-80 years of age * Current smoker, or former smoker with a cessation history of \< 15 years * \>= 30 pack-year smoking history * English-speaking Exclusion Criteria: * CALLERS (SMOKERS WHO CONTACT THE QUITLINE ABOUT SMOKING CESSATION SERVICES) EXCLUSION CRITERIA * History of lung cancer by self-report
Contact & Investigator
Robert J Volk
PRINCIPAL INVESTIGATOR
M.D. Anderson Cancer Center
Frequently Asked Questions
Who can join the NCT04595422 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Lung Carcinoma. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04595422 currently recruiting?
Yes, NCT04595422 is actively recruiting participants. Contact the research team at bvolk@mdanderson.org for enrollment information.
Where is the NCT04595422 trial being conducted?
This trial is being conducted at Houston, United States.
Who is sponsoring the NCT04595422 clinical trial?
NCT04595422 is sponsored by M.D. Anderson Cancer Center. The principal investigator is Robert J Volk at M.D. Anderson Cancer Center. The trial plans to enroll 800 participants.